Definium Therapeutics, Inc.

DFTX ·Healthcare, Drug Manufacturers - General, United States

← 5Y 10Y MAX →

Returns on Capital

ROE ROI ROA

Fiscal Year	ROE	ROI	ROA
FY2024	-45.0%	-41.3%	-36.0%
FY2025	-55.3%	-49.3%	-41.8%